Pharmabiz

Boehringer Ingelheim expands investment in computational innovation with new AI accelerator in UK’s Knowledge Quarter

Boehringer Ingelheim announced the expansion of its global Computational Innovation footprint with the launch of a new centre ...
Pharmabiz

C-CAMP with Imperial College London, to open Indo-UK Life Sciences Innovation Corridor for cooperation in biology research & entrepreneurship

Centre for Cellular and Molecular Platforms (C-CAMP) has signed an MoU with Imperial College London, to institute a ...
Pharmabiz

Merck and Eisai provide update on phase 3 LITESPARK-012 trial evaluating first-line combination treatments for certain patients with advanced RCC

Merck, known as MSD outside of the United States and Canada, and Eisai announced results from the phase 3 LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients ...
Pharmabiz

Merck unveils first bio-based solvent portfolio for high-performance liquid chromatography

Merck, a leading science and technology company, has launched the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable ...
Pharmabiz

Supriya Lifescience’s Maharashtra API facility receives US FDA EIR with VAI classification

Supriya Lifescience Limited, a leading API manufacturer, announced the US FDA has issued an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) classification for its API ...
Pharmabiz

Atal MedTech Museum & Library unveiled by M Venkaiah Naidu at AMTZ

The Atal MedTech Museum & Library, a one-of-a-kind centre was inaugurated today at Andhra Pradesh MedTech Zone (AMTZ) by Hon’ble Former Vice President of India M. Venkaiah Naidu, marking a significant ...
Pharmabiz

Allurion Technologies marks major milestone, treats first commercial patients in United States

Allurion Technologies Inc, a pioneer in metabolically healthy weight loss, announced the successful commercial treatment of its first patients in the United States - an inflection point that formally ...
Pharmabiz

Addex Therapeutics’ GABAB PAM candidate shows robust anti-tussive activity in non-human primate chronic cough model

Addex Therapeutics’ GABAB PAM candidate shows robust anti-tussive activity in non-human primate chronic cough model: Geneva, Switzerland Wednesday, April 22, 2026, 18:00 Hrs [IS ...
Pharmabiz

Greenspace Herbs launches Curcumin QA designed for higher absorption at lower doses

Greenspace Herbs launches Curcumin QA designed for higher absorption at lower doses: Our Bureau, Bengaluru Wednesday, April 22, 2026, 17:25 Hrs [IST] Bengaluru-based Greenspace He ...
Pharmabiz

Argo Biopharma begins patient dosing in phase II trials of siRNA therapy BW-40202

Argo Biopharma begins patient dosing in phase II trials of siRNA therapy BW-40202: Shanghai, China Wednesday, April 22, 2026, 15:00 Hrs [IST] Argo Biopharmaceutical Co., Ltd. (Arg ...
Pharmabiz

Aahwahan Foundation distributes 1,000 wheelchairs to differently-abled individuals at Victoria Hospital

Aahwahan Foundation has distributed of 1,000 fully automated wheelchairs to underprivileged and differently-abled individuals ...
Pharmabiz

Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial

Positive high-level results from a prespecified interim analysis of the I CAN phase III trial showed that Ultomiris (ravulizumab) met its primary endpoint, demonstrating a statistically significant ...